Itepekimab | Interleukin Related interleukin-related.com

Product Name :
Itepekimab

Search keywords :
Itepekimab

drugId :
null

Target Vo:
Interleukin-33

Target Vo Short Name :
IL33

Moa_Name:
Interleukin-33 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :
Genzyme Ireland Ltd

Active Indication_Name:
Pulmonary Disease, Chronic Obstructive

In Active Indication_Name:
Dermatitis, Atopic

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
8-OHdG (DNA/RNA Damage) Antibody Epigenetic Reader Domain
Pepinemab supplier
APOA1 Antibody: APOA1 Antibody is an unconjugated, approximately 28 kDa, rabbit-derived, anti-APOA1 polyclonal antibody. APOA1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, chicken, and predicted: pig, cow background without labeling.

Author: Interleukin Related

Related Posts